mRNA Vaccine Pharmacovigilance: Model Integration and

Data Characteristics for this Category

mRNA vaccine pharmacovigilance data originates from global and regional drug regulatory agency databases, clinical trial reports, and post-market real-world data (e.g., electronic health records, social media monitoring). Data updates frequently. Regulatory databases typically update daily or weekly. Clinical trial data publishes periodically as research progresses. Document structures vary, including structured case report forms (CRFs), unstructured medical text (e.g., doctor's notes, patient descriptions), and semi-structured drug labels and regulatory documents. Fields and units are specific to the biomedical domain. Examples include gene sequence information, antigen expression levels, immune response indicators (e.g., antibody titer in IU/mL), and adverse event MedDRA (Medical Dictionary for Regulatory Activities) codes.

Constraints Imposed by These Characteristics on Model Integration and Configuration

High-frequency data sources require flexible incremental update mechanisms for model integration. This avoids reprocessing historical data. Diverse document structures necessitate support for multimodal data input and effective information extraction from unstructured text. The presence of specialized terminology, especially MedDRA codes, demands higher capabilities for entity recognition and relation extraction. This requires specialized domain dictionaries and pre-trained models. Furthermore, mRNA vaccine-specific data, such as gene sequences and immunological indicators, may require customized data preprocessing. Examples include encoding transformation for gene sequences or normalization for immune response data. Processing large volumes of unstructured text has specific requirements for tokenization strategies and vectorization model selection to ensure semantic accuracy.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`Chunk size` (Chunk Size)	`800–1200 characters`	Balances context completeness with model processing efficiency, suitable for medical text paragraph structures.
`Recall count` (Recall Count)	`top 10`	Ensures coverage of potentially relevant information, addressing multi-dimensional descriptions in adverse event reports.
`Similarity threshold` (Similarity Threshold)	`0.75`	Filters low-relevance content, improves recall accuracy, especially for specialized terminology matching.
`Rerank result count` (Rerank Return Count)	`top 3`	Refines final results, focusing on the most relevant adverse event or drug interaction information.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Addresses parsing requirements for large clinical trial reports or complex regulatory documents.
`maxContext`	`24000 characters`	Accommodates more contextual information, handling lengthy patient histories or adverse reaction descriptions.

Common Pitfalls

The rerank result field in knowledge base query results displays false. This indicates low quality answers. The reranking model may not be correctly loaded or configured, failing to effectively reorder recall results.
The model encounters a 422 "Messages token length must..." error when processing locally deployed medical image or video data. This indicates the model cannot operate normally or returns error messages. The token length of feature vectors converted from images or videos exceeds the model's context window limit.
The model fails to identify new specific adverse reaction patterns when faced with new mRNA vaccine batch data. This indicates the model's answers omit critical information. The knowledge base update mechanism did not synchronize the latest data in time, or the model did not undergo incremental training to adapt to the new data distribution.

Verification Steps

Upload the latest batch of mRNA vaccine clinical trial data. Check the knowledge base index status to ensure all documents are successfully parsed and indexed.
Submit multi-turn questions for known mRNA vaccine adverse event cases. Verify the accuracy and completeness of MedDRA codes, symptom descriptions, and associated drug information mentioned in the model's answers.
Simulate an urgent pharmacovigilance scenario. Ask questions containing complex medical terminology and vague descriptions. Evaluate if the model can accurately recall and extract highly relevant information under the configured Similarity threshold (similarity threshold) and Rerank result count (rerank return count) settings.

The values provided are common starting points. Measure performance against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.